Rossari Biotech Reports Strong Financial Performance in Q2 FY25

Oct 19 2024 06:46 PM IST
share
Share Via
Rossari Biotech, a smallcap chemicals company, has reported a positive financial performance in the quarter ending September 2024, with a score of 6 out of 7. The company's Profit Before Tax and Net Sales have shown consistent growth, while Operating Profit and Profit After Tax have reached new highs. Earnings per Share have also increased, indicating a promising future for the company.

Rossari Biotech, a smallcap company in the chemicals industry, has recently announced its financial results for the quarter ending September 2024. The company’s stock has been given a ‘Hold’ call by MarketsMOJO.

According to the financial report, Rossari Biotech has shown a positive performance in the quarter, with a score of 6 out of 7. This is a slight decrease from the previous quarter’s score of 7, but still reflects a strong financial performance.


One of the key factors contributing to this positive performance is the company’s Profit Before Tax (PBT) less Other Income, which has been consistently growing in the last five quarters and reached a high of Rs 47.39 crore in the September 2024 quarter. This trend is expected to continue in the near term.


The company’s Net Sales have also been on an upward trend, reaching a high of Rs 498.35 crore in the last five quarters. This indicates a positive sales trend in the near term.


Rossari Biotech’s Operating Profit (PBDIT) has also shown a positive trend, with a high of Rs 65.94 crore in the last five quarters. Similarly, the company’s Profit After Tax (PAT) has been consistently increasing, reaching a high of Rs 35.33 crore in the September 2024 quarter.


The company’s Earnings per Share (EPS) have also been on the rise, reaching a high of Rs 6.39 in the last five quarters. This indicates that the company has been able to generate higher earnings for its shareholders.


Overall, Rossari Biotech’s financial performance in the September 2024 quarter has been positive, with strong growth in key areas. This is a promising sign for the company and its investors.


{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News